Evidence map›Paper›PMID 38991747›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy.

Ghadah Al-Naqeeb, Eric Munger, Amrita L Ramanathan, Andrew Makarewicz, Noha Behairy, Padmasree Veraraghavan, Craig Cochran, Philip Bernaldez, Iman Clinton, Newbegin Devaraj and 7 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ghadah Al-NaqeebMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Eric MungerDivision of Radiation Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland.
Amrita L RamanathanClinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Andrew MakarewiczMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Noha BehairyMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Padmasree VeraraghavanMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Craig CochranMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Philip BernaldezMedical Surgical Specialties, Clinical Center Nursing Department, National Institutes of Health, Bethesda, Maryland; and.
Iman ClintonMedical Surgical Specialties, Clinical Center Nursing Department, National Institutes of Health, Bethesda, Maryland; and.
Newbegin DevarajDivision of Radiation Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland.
Korressa LeeDivision of Radiation Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland.
Teresa FisherDivision of Radiation Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland.
Olumide OwoadeDivision of Radiation Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland.
Roberto Maass-MorenoDepartment of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland.
Babak SabouryDepartment of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland.
Sriram GubbiMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Joanna Klubo-GwiezdzinskaMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; joanna.klubo-gwiezdzinska@nih.gov.

Funding

Studies of Benign and Malignant Thyroid DiseaseZIADK047053 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KLUBO-GWIEZDZINSKA, JOANNA · 2009 to 2025
$4.3M
6 · The paper itself

Abstract

High-activity radioactive iodine (RAI) therapy for metastatic thyroid cancer (TC) requires isolation to minimize radiation exposure to third parties, thus posing challenges for patients needing hands-on care. There are limited data on the approach to high-activity RAI treatment in paraplegic patients. We report a state-of-the-art multidisciplinary approach to the management of bedbound patients, covering necessary radiation safety measures that lead to radiation exposure levels as low as reasonably achievable. Given the limited literature resources on standardized approaches, we provide a practical example of the safe and successful treatment of a woman with

Indexed as

Iodine RadioisotopesParaplegiaThyroid Cancer, PapillaryThyroid NeoplasmsAgedFemaleHumansNeoplasm MetastasisPatient Care TeamTreatment OutcomeIodine Radioisotopesmetastasesparaplegiaradioactive iodinethyroid cancer

Identifiers

PMID38991747
PMCPMC11372254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.